Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
25199-1 Rifabutin 1.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25199-1 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Rifabutin 1 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1 ug/mL; AFB; Ansamycin; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutin; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
252-7 5-Fluorocytosine Susc Isolate Pt Qn MLC &nbsp; ACTIVE 5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 252-7 &nbsp; MLC &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 5-fluorocytosine Islt MLC &nbsp; &nbsp; &nbsp; Y &nbsp; Alcobon; Ancobon; Ancotil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Flucytosine; Fluorocytosin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.21 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
2520-5 Lactate SCnc CSF Pt Qn &nbsp; &nbsp; ACTIVE Lactate [Moles/volume] in Cerebral spinal fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 2520-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Lactate CSF-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
25200-7 Rifabutin 2.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25200-7 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Rifabutin 2 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2 ug/mL; AFB; Ansamycin; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutin; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25201-5 Rifabutin 4.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25201-5 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Rifabutin 4 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4 ug/mL; AFB; Ansamycin; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutin; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25202-3 rifAMPin 1.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE rifAMPin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25202-3 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 rifAMPin 1 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; RIF; Rifadin; Rifampicin; Rimactane; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25203-1 rifAMPin 2.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE rifAMPin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25203-1 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 rifAMPin 2 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; RIF; Rifadin; Rifampicin; Rimactane; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25204-9 rifAMPin 5.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE rifAMPin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25204-9 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 rifAMPin 5 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 5 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; RIF; Rifadin; Rifampicin; Rimactane; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25205-6 Streptomycin 2.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25205-6 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Streptomycin 2 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2 ug/mL; AFB; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c232; C295; Cidam est; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Novostrep; Point in time; Random; SlowMyco; Solustrep; Streptocol; Strepto-fatol; Streptomyc; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25206-4 Streptomycin 10.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25206-4 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Streptomycin 10 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 10 ug/mL; AFB; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c232; C295; Cidam est; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Novostrep; Point in time; Random; SlowMyco; Solustrep; Streptocol; Strepto-fatol; Streptomyc; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25207-2 cycloSERINE 10.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE cycloSERINE 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25207-2 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 cycloSERINE 10 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 10 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Closina; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Oxamycin; Point in time; Random; Seromycine; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25208-0 cycloSERINE 20.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE cycloSERINE 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25208-0 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 cycloSERINE 20 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 20 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Closina; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Oxamycin; Point in time; Random; Seromycine; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25209-8 cycloSERINE 30.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE cycloSERINE 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25209-8 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 cycloSERINE 30 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 30 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Closina; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Oxamycin; Point in time; Random; Seromycine; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
2521-3 Lactate PrThr Gast fld Pt Ord &nbsp; &nbsp; ACTIVE Lactate [Presence] in Gastric fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 2521-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Lactate Gast Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; GAST; Gastric contents; Gastric fluid; Lact; Lactic acid; L-lactate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen 2.56 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
25210-6 Capreomycin 10.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25210-6 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Capreomycin 10 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 10 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; CAPASTAT; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Ogostal; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25211-4 Capreomycin 20.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25211-4 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Capreomycin 20 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 20 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; CAPASTAT; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Ogostal; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25212-2 Capreomycin 30.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25212-2 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Capreomycin 30 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 30 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; CAPASTAT; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Ogostal; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25213-0 Kanamycin 6.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25213-0 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Kanamycin 6 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kantrex; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25214-8 Kanamycin 30.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25214-8 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Kanamycin 30 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 30 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kantrex; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25215-5 Para aminosalicylate 2.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25215-5 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 PAS 2 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2 ug/mL; AFB; Aminosalicycic; Aminosalycilate; ANTIBIOTIC SUSCEPTIBILITIES; AST; Epusal; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; NA-PAS; Nemasol sodium; p-aminosalicyclic acid; Para aminosalicylic acid; PAS; Point in time; Random; Salf-pas; SlowMyco; Sodico; Sodium PAS; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Therazid; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25216-3 Para aminosalicylate 8.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25216-3 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 PAS 8 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 8 ug/mL; AFB; Aminosalicycic; Aminosalycilate; ANTIBIOTIC SUSCEPTIBILITIES; AST; Epusal; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; NA-PAS; Nemasol sodium; p-aminosalicyclic acid; Para aminosalicylic acid; PAS; Point in time; Random; Salf-pas; SlowMyco; Sodico; Sodium PAS; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Therazid; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25217-1 Isoniazid 0.1 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25217-1 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Isoniazid 0.1 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Hyzyd; ID; Infectious Disease; InfectiousDisease; INH; Islt; Isol; Isoniaz; Isoniazide; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Nudrazod; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25218-9 Isoniazid 0.2 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25218-9 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Isoniazid 0.2 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Hyzyd; ID; Infectious Disease; InfectiousDisease; INH; Islt; Isol; Isoniaz; Isoniazide; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Nudrazod; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25219-7 Isoniazid 1.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25219-7 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Isoniazid 1 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Hyzyd; ID; Infectious Disease; InfectiousDisease; INH; Islt; Isol; Isoniaz; Isoniazide; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Nudrazod; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
2522-1 Lactate SCnc Plr fld Pt Qn &nbsp; &nbsp; ACTIVE Lactate [Moles/volume] in Pleural fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 2522-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Lactate Plr-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Lact; Lactic acid; Level; L-lactate; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; thoracentesis fluid 2.42 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
104,672 results found